Risk prediction model for disease behavior symptom cluster among patients with lung cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027297

Enrollment

Unknown

Registered

2019-11-08

Start date

2020-02-17

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Lung cancer patients with disease behavior symptom cluster:N/A

Chronic non-cancer lung disease patients with disease behavior symptom cluster:N/A

control group:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Experimental group: a. Lung cancer patients with disease behavior symptom cluster : 1. 18 years old < age < 70 years old; 2. Patients diagnosed with lung cancer by pathology and CT for the first time, and patients who received chemotherapy for the first time. 3. Having a certain cognitive and language skills to accurately describe their own symptoms and psychological feelings. 4. Willing to cooperate. b. Chronic non-cancer lung disease patients with disease behavior symptom cluster: 1. 18 years old < age < 70 years; 2. Clinically diagnosed as chronic non-cancer lung disease, such as COPD, bronchial asthma, etc. 3. Having a certain cognitive and language skills to accurately describe their own symptoms and psychological feelings. 4. Willing to cooperate. Control group: 1. 18 years old < age < 70 years old; 2. Clinically confirmed healthy people, including participants in hospital outpatient or physical examination centers; 3. Willing to cooperate.

Exclusion criteria

Exclusion criteria: Experimental group: a. Lung cancer patients with disease behavior symptom cluster: 1. Combined with other malignant tumors. 2. Cognitive dysfunction. 3. The condition is heavy or unstable. b. Chronic non-cancer lung disease patients with disease behavior symptom cluster: 1. Combined with other chronic or acute inflammatory diseases. 2. Cognitive dysfunction. 3. The condition is heavy or unstable. Control group: 1. The family members of the study subjects.

Design outcomes

Primary

Measure	Time frame
Cytokine;T cell subset;disease behavior symptom cluster with lung cancer;Quality of Life;Social support;	—

Secondary

Measure	Time frame
C-reactive protein;Blood routine;BMI;	—

Countries

China

Contacts

Public ContactLili Zhang

School of Nursing, Southern Medical University

zhanglili_gz@126.com+86 18665000133

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026